Medications Approved for the Treatment of Parkinson’s Disease in the USA EDUCATIONAL SUPPLEMENT

First Page		Document Content
Date: 2016-01-07 11:17:11 Catecholamines Combination drugs Catechols Nitrobenzenes Dopamine agonists L-DOPA Carbidopa/levodopa/entacapone Carbidopa Entacapone Catechol-O-methyl transferase Tolcapone Selegiline		Medications Approved for the Treatment of Parkinson’s Disease in the USA EDUCATIONAL SUPPLEMENT Add to Reading List Source URL: www.apdaparkinson.org Download Document from Source Website File Size: 82,91 KB Share Document on Facebook

	Models of probabilistic category learning in Parkinson’s disease: Strategy use and the effects of L-dopa Maarten Speekenbrink a,∗ David A. Lagnado a Leonora Wilkinson b Marjan Jahanshahi b David R. Shanks a b Sobell DocID: 1tXVx - View Document
	Journal of Applied Biology & Biotechnology Vol), pp, Jan-Feb, 2016 Available online at http://www.jabonline.in DOI: JABBProperties of phenoloxidase from haemocytes of Scylla tranquebar DocID: 1qD0u - View Document
	Medications Approved for the Treatment of Parkinson’s Disease in the USA EDUCATIONAL SUPPLEMENT DocID: 1orKd - View Document
	article published online: 18 may 2015 \| doi: nchembio.1816 An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose DocID: 1fy3Q - View Document
	Performance analysis of OFDM modulation on indoor broadband PLC channels DocID: 1aXbr - View Document